[{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0036/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0036/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0035/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0035/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0034/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0034/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0033/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0033/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0032/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0032/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0031/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0031/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0030/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0030/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002f/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002f/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002e/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002e/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002d/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002d/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002c/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002c/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002b/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002b/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc002a/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc002a/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0029/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0029/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0028/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0028/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0027/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0027/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0026/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0026/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0025/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0025/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0024/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0024/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0023/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0023/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0022/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0022/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0021/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0021/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc0020/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc0020/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc001f/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc001f/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc001e/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc001e/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc001d/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc001d/interview.png"},{"image":"https://icons.biorender.com/w75xh75/5ea2095009b1400028bc001c/interview.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5ea2095009b1400028bc001c/interview.png"}]